Malin Corporation plc (ISE: MLC)
Health Care · Life Sciences Tools & Services · IE
€7.00
+2.94% today · -19.1% 1Y
Malin Corporation plc (ISE: MLC) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $33.98M and employs 2 people.
Over the last twelve months the share price has lost 19.1%, trading between 6.80 and 9.30.
Tweenvest scores Malin Corporation plc across four factors: quality 47/100, value 57/100. Its strongest factor is value.
MLC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $33.98M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.92
- Dividend yield
- —
- Beta (5Y)
- 0.42
- 52-week high
- €9.30
- 52-week low
- €6.80
- Avg volume (3M)
- —
- Shares outstanding
- 4.34M
- Employees
- 2
- Next earnings
- —
About Malin Corporation plc
Malin Corporation plc operates as a life sciences firm across Ireland and the United States, primarily through its various subsidiaries. The company specializes in developing and delivering vital solutions for critical medical challenges. Its portfolio includes groundbreaking cell and gene therapies aimed at patients with significant unmet medical requirements. Furthermore, Malin provides treatments targeting pressing needs in oncology, infectious diseases, and autoimmune conditions. It also addresses specific women's health concerns, such as recurrent vulvovaginal candidiasis, and offers remedies for fungal nail infections like onychomycosis. Beyond these, Malin's offerings extend to pharmaceutical products for protein misfolding disorders, a sophisticated platform designed to identify pathogenic bacteria within the gut microbiome, and advanced UV-light disinfection technologies. Additionally, it offers corporate secretarial services. Established in 2014, Malin Corporation plc maintains its headquarters in Dublin, Ireland.
- ISIN
- IE00BVGC3741
- Founded
- 2014
- Listed since
- Mar 25, 2014
- Exchange
- Irish Stock Exchange
- Currency
- EUR
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Harvard Bioscience, Inc.NasdaqCM: HBIO | $37.51M | $8.49 | +3.03% |
| ORIENT BIO Inc.KOSE: A002630 | $36.12M | ₩1,638.00 | -0.12% |
| P&K Skin Research Center Co., Ltd.KOSDAQ: A347740 | $36.09M | ₩1,680.00 | +1.82% |
| Green Lifescience Co., Ltd.KOSDAQ: A114450 | $34.86M | ₩2,400.00 | +4.80% |
| Trajan Group Holdings LimitedASX: TRJ | $30.40M | AU$0.29 | +21.28% |
| Bioqual, Inc.OTCPK: BIOQ | $29.52M | $— | — |
| Kolmar BioTech, Inc.KOSDAQ: A215380 | $28.67M | ₩2,290.00 | -1.29% |
| Radnostix, Inc.OTCPK: INIS | $28.57M | $0.05 | -14.29% |
Figures last refreshed Oct 11, 2026.